Long-Term Efficacy and Safety Outcomes After Unrestricted Use of Drug-Eluting Stents in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Long-Term Efficacy and Safety Outcomes After Unrestricted Use of Drug-Eluting Stents in Patients With Acute Coronary Syndrome

Published:2014 Issue:7 Volume:78 Page:1628-1635
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kawaji Tetsuma¹,Shiomi Hiroki¹,Morimoto Takeshi²,Tamura Toshihiro³,Nishikawa Ryusuke¹,Yano Mariko¹,Tazaki Junichi¹,Imai Masao¹,Saito Naritatsu¹,Makiyama Takeru¹,Shizuta Satoshi¹,Ono Koh¹,Kimura Takeshi¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

2. Division of General Medicine, Department of Internal Medicine, Hyogo College of Medicine

3. Department of Cardiovascular Medicine, Tenri Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/7/78_CJ-13-1388/_pdf

Reference23 articles.

1. 1. SabateM,CequierA,IñiguezA,SerraA,Hernandez-AntolinR,MainarV, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION) : 1 year results of a randomised controlled trial. Lancet 2012; 380: 1482–1490.

2. 2. RaberL,KelbaekH,OstojicM,BaumbachA,HegD,TullerD, et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction : The COMFORTABLE AMI randomized trial. JAMA 2012; 308: 777–787.

3. 3. O’GaraPT,KushnerFG,AscheimDD,CaseyDE Jr,ChungMK,deLemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions.Catheter Cardiovasc Interv 2013; 82: E1–E27, doi:10.1002/ccd.24776.

4. 4. SerruysPW,UngerF,SousaJE,JateneA,BonnierHJ,SchonbergerJP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117–1124.

5. 5. CutlipDE,WindeckerS,MehranR,BoamA,CohenDJ,vanEs GA, et al. Clinical end points in coronary stent trials : A case for standardized definitions. Circulation 2007; 115: 2344–2351.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Propensity Score-Matched Comparison of Midterm Outcomes Between Drug-Coated Balloons and Drug-Eluting Stents for Patients with Acute Coronary Syndrome;International Heart Journal;2022-03-30

2. Long-Term Efficacy and Safety of Everolimus-Eluting Stent Implantation in Japanese Patients with Acute Coronary Syndrome: Five-Year Real-World Data from the Tokyo-MD PCI Study;Journal of Interventional Cardiology;2019-11-03

3. Frequency and predictors of bleeding events after 2nd generation drug-eluting stent implantation differ depending on time after implantation;Journal of Cardiology;2017-04

4. Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation;Therapeutic Advances in Cardiovascular Disease;2016-02-25

5. Predictors of Long Term Outcomes in 11,441 Consecutive Patients Following Percutaneous Coronary Interventions;The American Journal of Cardiology;2015-04